肝细胞癌的治疗策略:当更少不是更多时
Gabriel Lazzarotto-da-Silva1, Fabiane A Marek1, Marcio F Chedid1
1Liver Transplant and Hepatobiliary Surgery, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Current pharmaceutical design
|March 16, 2026
概括
与单一方法相比,结合疗法在肝细胞癌 (HCC) 治疗中提供了更好的结果. 这种方法,包括免疫检查点抑制剂,正在彻底改变HCC管理.
科学领域:
- 肝胆道医学 肝胆道医学
- 手术瘤学手术瘤学
- 免疫治疗是一种免疫疗法.
背景情况:
- 肝细胞癌 (HCC) 治疗包括手术,局部治疗 (LRT) 和全身治疗.
- 先进的HCC治疗已被免疫检查点抑制剂增强.
- 优化个人HCC患者的治疗策略仍然是一个复杂的挑战.
研究的目的:
- 评估组合疗法与单疗法对HCC的疗效.
- 探索免疫检查点抑制剂在各种HCC治疗环境中的作用.
- 确定结合治疗方法是否可以改善HCC患者的治疗结果.
主要方法:
- 随机临床试验和临床场景的审查,涉及HCC治疗.
- 对不可切除的HCC的TACE与切除 (RFA/MWA) 等组合疗法的分析.
- 评估免疫检查点抑制剂作为辅助或新辅助疗法在HCC管理.
主要成果:
- 组合治疗,如TACE与RFA/MWA,与TACE单独治疗相比,在不可切除的HCC中显示出更好的结果.
- 切除或TACE后的辅助免疫检查点抑制剂可能会提高无复发的生存率.
- 在不同的HCC临床环境中,组合治疗越来越受青,而不是单一治疗.
结论:
- 结合治疗方式,包括手术切除,LRT和免疫治疗,比单独治疗HCC更有效.
- 免疫检查点抑制剂的整合到多模式治疗策略中,代表了HCC护理的重大进步.
- 传统的"少就多"的方法正在被"多就多"的策略所取代,以有效地管理HCC.
相关概念视频
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Cancer Therapies
10.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.6K


